MedPageToday -- Patients with the second most common genetic mutation seen in cystic fibrosis showed substantial improvement when treated with an investigational oral drug that boosts chloride transport in the lungs, results of a small study showed.
MedPageToday -- Patients with the second most common genetic mutation seen in cystic fibrosis showed substantial improvement when treated with an investigational oral drug that boosts chloride transport in the lungs, results of a small study showed.
